With 76.92% of patients showing higher expression in cancer tissue, the transcriptional level of CLDN4 was significantly higher in the GC tissues compared with matched non-tumorous adjacent tissues via Wilcoxon’s Sign Rank Test (P < 0.001, Fig. 3e, Supplementary Fig. 4e). The gene discussed is CLDN4; the disease is cancer.